Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Breast Neoplasms 255Neoplasms 220Carcinoma, Non-Small-Cell Lung 201Colorectal Neoplasms 146Prostatic Neoplasms 136Lung Neoplasms 118Ovarian Neoplasms 100Neoplasm Metastasis 100Multiple Myeloma 96Pancreatic Neoplasms 89Leukemia, Myeloid, Acute 80Squamous Cell Carcinoma of Head and Neck 70Melanoma 64Endometrial Neoplasms 64Stomach Neoplasms 59Recurrence 57Glioblastoma 55Brain Neoplasms 54Urinary Bladder Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Carcinoma, Hepatocellular 50Lymphoma 48Triple Negative Breast Neoplasms 47Carcinoma, Renal Cell 45Head and Neck Neoplasms 44Esophageal Neoplasms 44Glioma 43Lymphoma, Non-Hodgkin 42Hematologic Neoplasms 42Uterine Cervical Neoplasms 39

Interventions

selinexor 1pazopanib 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Chondrosarcoma, Extraskeletal Myxoid × 30 days × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡